Amgen strives to deliver successful treatments to patients. This goes well beyond the development of innovative medicines and preventive therapies. We provide services, advice and new solutions that contribute to a better and more efficient healthcare system. We do this in the following fields:
Oncology and hematology
- Particular types of cancer involving tumor formation, such as breast cancer, colorectal cancer, prostate cancer, skin cancer
- Hematological types of cancer (cancers of particular blood cells) such as Acute Lymphoblastic Leukemia (ALL) and Multiple Myeloma (MM)
- Immune Mediated Trombocytopenia (ITP) - a disease whereby the immune system destroys the body’s own platelets
- A shortage of white or red blood cells due to chemotherapy
Kidney diseases
- Severe renal failure in the predialysis or dialysis stage
Bone diseases
- Osteoporosis - in post-menopausal women and also in men
- Bonecomplications caused by bonelesions or bonemetastases (dissemination of cancer in the bone) in patients with advanced cancer.
Cardiovascular diseases
- Elevated LDL cholesterol (the bad cholesterol) in patients with a very high risk of cardiovascular diseases, for whom currently available drugs have not yet succeeded in lowering the LDL cholesterol level sufficiently
Inflammatory diseases
- Rheumatic diseases such as rheumatoid arthritis
- Bowel disorders such as Crohn's disease and Colitis Ulcerosa
- Skin diseases such as psoriasis
- Eye diseases such as uveitis
In addition, Amgen has developed a range of activities and services that contribute to sustainable care.
